SPY308.08+2.53 0.83%
DIA257.85+2.58 1.01%
IXIC9,608.38+56.33 0.59%

Seneca Biopharma Q1 EPS $(0.930) Up From $(3.420) YoY, Sales $6.020M Up From $2.500K YoY

Seneca Biopharma (NASDAQ:SNCA) reported quarterly losses of $(0.930) per share. This is a 72.81 percent increase over losses of $(3.420) per share from the same period last year. The company reported $6.020 million in

Benzinga · 05/15/2020 12:05

Seneca Biopharma (NASDAQ:SNCA) reported quarterly losses of $(0.930) per share. This is a 72.81 percent increase over losses of $(3.420) per share from the same period last year. The company reported $6.020 million in sales this quarter. This is a 240.70K percent increase over sales of $2.500 thousand the same period last year.